- CEO
- Shun Ming Cai
- Full Time Employees
- 138
- Sector
- Finance
- Industry
- Real estate development
- Address
- Dongyin Center Shanghai SH China 201103
- IPO Date
- Jul 9, 2002
- Business
- Deluxe Family Co., Ltd. (Shanghai Stock Exchange: 600503.SS) is a China-based company principally engaged in real estate development, management, and sales; equity investment management; and high-tech materials production. The company develops, manages, and sells residential, commercial, and office properties, with representative projects including La VUE, Aqua Vista, Deluxe Family Pudong Garden, Deluxe Family Gubei Garden, and Sandalwood; it also undertakes supporting services such as building decoration, greening, environmental protection, and commercial investment. Through subsidiaries like Chongqing Graphene Technology Co., Ltd., Ningbo Morsh Tech Co., Ltd., and Ningbo Morsh New Material Co., Ltd., Deluxe Family produces graphene microsheets, graphene films, and related high-tech materials; additionally, it engages in financial investments, investment consulting, and equity operations in environmental protection and other sectors.
Founded in 2000 as Shanghai Deluxe Family Real Estate Development Co., Ltd. and listed on the Shanghai Stock Exchange in 2008 following a name change and asset injection, the company is headquartered in Shanghai, China, with primary operations in the Yangtze River Delta region including Shanghai, Suzhou, and Zunyi.
In recent developments, Deluxe Family announced in August 2025 a strategic investment of up to CNY 300 million in cash to acquire 5% to 8.09% equity in innovative biopharmaceutical firm Shanghai Haihe Pharmaceuticals (Haihe Drugs), marking a diversification into the healthcare sector amid real estate market challenges. The company maintains involvement in technology investments, including graphene and robotics via Siasun Robot & Automation, and established a new real estate subsidiary in Shanghai to support ongoing property development. Previously, it pursued acquisitions such as Beijing Morsh through its venture capital arm and divested its stake in Huatai Futures in 2022 to streamline operations.